These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Arnold JC; Topple AN; Mallet PE; Hunt GE; McGregor IS Brain Res; 2001 Dec; 921(1-2):240-55. PubMed ID: 11720732 [TBL] [Abstract][Full Text] [Related]
47. Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression. Colussi-Mas J; Schenk S Eur J Neurosci; 2008 Nov; 28(9):1895-910. PubMed ID: 18973603 [TBL] [Abstract][Full Text] [Related]
48. 5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence. Martin CB; Martin VS; Trigo JM; Chevarin C; Maldonado R; Fink LH; Cunningham KA; Hamon M; Lanfumey L; Mongeau R Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522398 [TBL] [Abstract][Full Text] [Related]
49. Antidepressants attenuate both the enhanced ethanol intake and ethanol-induced anxiolytic effects in diazepam withdrawn rats. Martijena ID; Bustos SG; Bertotto ME; Molina VA Eur Neuropsychopharmacol; 2005 Jan; 15(1):119-30. PubMed ID: 15572281 [TBL] [Abstract][Full Text] [Related]
50. Preclinical characterization of ACH-000029, a novel anxiolytic compound acting on serotonergic and alpha-adrenergic receptors. Azevedo H; Ferreira M; Costa RW; Russo V; Russo E; Mascarello A; Guimarães CRW Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109707. PubMed ID: 31330215 [TBL] [Abstract][Full Text] [Related]
51. Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence. Popik P; Wróbel M; Nowak G Neuropharmacology; 2000 Sep; 39(12):2278-87. PubMed ID: 10974311 [TBL] [Abstract][Full Text] [Related]
52. The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drug. Inta D; Filipovic D; Lima-Ojeda JM; Dormann C; Pfeiffer N; Gasparini F; Gass P Neuropharmacology; 2012 Apr; 62(5-6):2034-9. PubMed ID: 22261382 [TBL] [Abstract][Full Text] [Related]
53. Effects of intracerebroventricular ethanol on ingestive behavior and induction of c-Fos immunoreactivity in selected brain regions. Crankshaw DL; Briggs JE; Olszewski PK; Shi Q; Grace MK; Billington CJ; Levine AS Physiol Behav; 2003 Jun; 79(1):113-20. PubMed ID: 12818716 [TBL] [Abstract][Full Text] [Related]
54. Effects of propranolol, buspirone, pCPA, reserpine, and chlordiazepoxide on open-field behavior. Angrini M; Leslie JC; Shephard RA Pharmacol Biochem Behav; 1998 Feb; 59(2):387-97. PubMed ID: 9476986 [TBL] [Abstract][Full Text] [Related]
55. The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze. Hinks GL; Brown P; Field M; Poat JA; Hughes J Eur J Pharmacol; 1996 Sep; 312(2):153-61. PubMed ID: 8894590 [TBL] [Abstract][Full Text] [Related]
56. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats. Rubino T; Sala M; Viganò D; Braida D; Castiglioni C; Limonta V; Guidali C; Realini N; Parolaro D Neuropsychopharmacology; 2007 Sep; 32(9):2036-45. PubMed ID: 17287821 [TBL] [Abstract][Full Text] [Related]
57. Anxiolytic potential of a microgram dose of chlordiazepoxide in the open-field test. Bruhwyler J Eur J Pharmacol; 1990 Oct; 187(3):547-9. PubMed ID: 1981557 [TBL] [Abstract][Full Text] [Related]
58. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Leonard SK; Dwyer JM; Sukoff Rizzo SJ; Platt B; Logue SF; Neal SJ; Malberg JE; Beyer CE; Schechter LE; Rosenzweig-Lipson S; Ring RH Psychopharmacology (Berl); 2008 May; 197(4):601-11. PubMed ID: 18311561 [TBL] [Abstract][Full Text] [Related]
59. Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. Day HE; Badiani A; Uslaner JM; Oates MM; Vittoz NM; Robinson TE; Watson SJ; Akil H J Neurosci; 2001 Jan; 21(2):732-40. PubMed ID: 11160452 [TBL] [Abstract][Full Text] [Related]
60. Induction of Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further evidence for withdrawal-induced anxiety. Knapp DJ; Duncan GE; Crews FT; Breese GR Alcohol Clin Exp Res; 1998 Apr; 22(2):481-93. PubMed ID: 9581657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]